Equifax Inc. · EFX · FY2023 Q4 · Calendar Q1 2024
Equifax maintains 2024 outlook as cloud and non-mortgage growth advance
The call supports a constructive but conditional view: resilient non-mortgage demand, cloud migration, cost actions, and new products support growth, while mortgage weakness and execution risks remain material.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about EFX FY2023 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the analysis shows guidance maintained rather than lowered, stronger quantified non-mortgage growth, continued cloud progress, and a more explicit focus on AI-enabled products and lower capital intensity.
Guidance delta
2024 guidance was maintained, including about 9% total revenue growth and $7.35 adjusted EPS.
Key takeaways
- Non-mortgage revenue grew 14% constant currency, led by Workforce Solutions and International.
- Cloud migration, cost actions, and product activity support the margin-expansion case.
- Mortgage remains the key near-term headwind, although management expects conditions to bottom.
Management priorities
- Complete the North American cloud migration.
- Deploy AI-enabled models and new products.
- Expand government contracts, payroll partnerships, and twin-record coverage.
Follow EFX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Outperform | Downgrade | Oct 26, 2026 |
| Argus Research | Buy | Hold | Upgrade | Oct 22, 2026 |
| Stifel | Buy | Buy | Maintain | Oct 21, 2026 |
| Needham | Buy | Buy | Maintain | Oct 21, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 21, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Oct 19, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 16, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 13, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 22, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Aug 21, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 19, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 9, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 15, 2025 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Dec 16, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Feb 13, 2024 |
| Truist Securities | Buy | Buy | Maintain | Feb 9, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jan 11, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jun 9, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 18, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 2, 2019 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 26, 2019 |
| Argus | Hold | Hold | Maintain | Sep 15, 2017 |
| William Blair | Outperform | Outperform | Maintain | Apr 8, 2016 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 30, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 18, 2014 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Feb 19, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $177.58. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Analyst unavailable | $189 | $182.36 | +6.4% | Oct 26, 2026 |
| Argus Research | John Eade | $200 | $175.57 | +12.6% | Oct 22, 2026 |
| BMO Capital | Analyst unavailable | $175 | $175.44 | -1.5% | Oct 21, 2026 |
| Deutsche Bank | Faiza Alwy | $201 | $175.12 | +13.2% | Oct 21, 2026 |
| Needham | Analyst unavailable | $210 | $176.54 | +18.3% | Oct 21, 2026 |
| Stifel Nicolaus | Analyst unavailable | $217 | $176.54 | +22.2% | Oct 21, 2026 |
| Loop Capital Markets | Analyst unavailable | $169 | $176.54 | -4.8% | Oct 20, 2026 |
| Mizuho Securities | Analyst unavailable | $185 | $161.25 | +4.2% | Oct 19, 2026 |
| RBC Capital | Analyst unavailable | $177 | $160.86 | -0.3% | Oct 16, 2026 |
| Goldman Sachs | George Tong | $148 | $139.73 | -16.7% | Oct 2, 2026 |
| Barclays | Analyst unavailable | $155 | $139.73 | -12.7% | Oct 2, 2026 |
| Credit Suisse | Analyst unavailable | $160 | $140.83 | -9.9% | Sep 30, 2026 |
| Goldman Sachs | George Tong | $171 | $145.78 | -3.7% | Sep 29, 2026 |
| Wells Fargo | Jason Haas | $200 | $158.62 | +12.6% | Sep 22, 2026 |
| BNP Paribas | Andrew Grobler | $245 | $177.05 | +38.0% | Sep 8, 2026 |
| Redburn Partners | Simon Clinch | $235 | $192.41 | +32.3% | Aug 21, 2026 |
| Deutsche Bank | Analyst unavailable | $208 | $169.84 | +17.1% | Jul 22, 2026 |
| Needham | Kyle Peterson | $245 | $173 | +38.0% | Jul 22, 2026 |
| Wells Fargo | Jason Haas | $212 | $173 | +19.4% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $225 | $173 | +26.7% | Jul 22, 2026 |
| Robert W. Baird | Analyst unavailable | $232 | $173 | +30.6% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $200 | $173 | +12.6% | Jul 22, 2026 |
| RBC Capital | Ashish Sabadra | $194 | $173 | +9.2% | Jul 22, 2026 |
| Goldman Sachs | George Tong | $182 | $173 | +2.5% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $167.22 | +18.3% | Jul 2, 2026 |
| Goldman Sachs | George Tong | $173 | $151.93 | -2.6% | Jun 26, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $154.84 | +23.9% | Jun 18, 2026 |
| UBS | Analyst unavailable | $215 | $165.13 | +21.1% | Jun 16, 2026 |
| UBS | Kevin McVeigh | $220 | $176.38 | +23.9% | Apr 23, 2026 |
| Mizuho Securities | Analyst unavailable | $222 | $186.85 | +25.0% | Apr 16, 2026 |
| Goldman Sachs | Analyst unavailable | $208 | $193.55 | +17.1% | Feb 6, 2026 |
| RBC Capital | Ashish Sabadra | $222 | $188.19 | +25.0% | Feb 5, 2026 |
| Needham | Analyst unavailable | $265 | $184.57 | +49.2% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $184.63 | +32.3% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $220 | $183.44 | +23.9% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $195 | $181.04 | +9.8% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $250 | $181.04 | +40.8% | Feb 5, 2026 |
| UBS | Analyst unavailable | $230 | $181.04 | +29.5% | Feb 5, 2026 |
| Barclays | Manav Patnaik | $215 | $181.04 | +21.1% | Feb 5, 2026 |
| Morgan Stanley | Toni Kaplan | $244 | $181.04 | +37.4% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $280 | $220.77 | +57.7% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $234 | $211.51 | +31.8% | Dec 8, 2025 |
| BMO Capital | Analyst unavailable | $245 | $229.93 | +38.0% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $253 | $231.31 | +42.5% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $285 | $228.33 | +60.5% | Oct 15, 2025 |
| Oppenheimer | Analyst unavailable | $271 | $230.81 | +52.6% | Oct 13, 2025 |
| UBS | Analyst unavailable | $297 | $256.25 | +67.3% | Sep 15, 2025 |
| UBS | Kevin McVeigh | $278 | $243.56 | +56.6% | Jul 23, 2025 |
| Bank of America Securities | Joshua Dennerlein | $285 | $255.08 | +60.5% | Jun 23, 2025 |
| RBC Capital | Ashish Sabadra | $300 | $243.45 | +68.9% | Mar 20, 2025 |
| BNP Paribas | Andrew Grobler | $305 | $260.55 | +71.8% | Dec 16, 2024 |
| Citigroup | Arthur Truslove | $331 | $285.2 | +86.4% | Oct 11, 2024 |
| BNP Paribas | Andrew Grobler | $310 | $297.57 | +74.6% | Sep 19, 2024 |
| Barclays | Manav Patnaik | $380 | $297.77 | +114.0% | Sep 13, 2024 |
| New Street | Toni Kaplan | $271 | $297.99 | +52.6% | Sep 12, 2024 |
| Needham | Kyle Peterson | $350 | $305.12 | +97.1% | Aug 28, 2024 |
| Wells Fargo | Jason Haas | $340 | $283.59 | +91.5% | Aug 12, 2024 |
| Needham | Kyle Peterson | $320 | $265.9 | +80.2% | Jul 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $305 | $264.19 | +71.8% | Jul 19, 2024 |
| Oppenheimer | Owen Lau | $300 | $260.3 | +68.9% | Jul 19, 2024 |
| Goldman Sachs | George Tong | $277 | $264.19 | +56.0% | Jul 18, 2024 |
| Evercore ISI | David Togut | $305 | $272.15 | +71.8% | Jul 18, 2024 |
| Oppenheimer | Owen Lau | $272 | $217.51 | +53.2% | Apr 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $265 | $217.51 | +49.2% | Apr 19, 2024 |
| Robert W. Baird | Jeffrey Meuler | $260 | $217.51 | +46.4% | Apr 19, 2024 |
| Morgan Stanley | Toni Kaplan | $240 | $217.51 | +35.2% | Apr 18, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $295 | $262.74 | +66.1% | Apr 9, 2024 |
| Evercore ISI | David Togut | $310 | $247.94 | +74.6% | Feb 13, 2024 |
| Deutsche Bank | Faiza Alwy | $267 | $230.38 | +50.4% | Dec 7, 2023 |
| RBC Capital | Ashish Sabadra | $205 | $202.29 | +15.4% | Apr 21, 2023 |
| Truist Financial | Analyst unavailable | $260 | $222.56 | +46.4% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $210 | $217.56 | +18.3% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $197 | $205.76 | +10.9% | Jan 4, 2023 |
| Stifel Nicolaus | Stifel Stifel | $222 | $192.63 | +25.0% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $219 | $201.85 | +23.3% | Nov 18, 2022 |
| Atlantic Equities | Simon Clinch | $230 | $207.1 | +29.5% | Nov 15, 2022 |
| Needham | Analyst unavailable | $230 | $193.99 | +29.5% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $212 | $172.07 | +19.4% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $230 | $193.99 | +29.5% | Jul 27, 2022 |
| Deutsche Bank | Analyst unavailable | $221 | $201.22 | +24.5% | Jul 22, 2022 |
| Truist Financial | Andrew Jeffrey | $230 | $200.56 | +29.5% | Jul 22, 2022 |
| Morgan Stanley | Analyst unavailable | $230 | $200.56 | +29.5% | Jul 22, 2022 |
| Credit Suisse | Analyst unavailable | $245 | $200.52 | +38.0% | Jul 21, 2022 |
| Stifel Nicolaus | Analyst unavailable | $223 | $183.14 | +25.6% | Jul 1, 2022 |
| Morgan Stanley | Toni Kaplan | $227 | $184.94 | +27.8% | Jun 28, 2022 |
| Evercore ISI | David Togut | $200 | $203.52 | +12.6% | Apr 29, 2022 |
| Barclays | Analyst unavailable | $250 | $206.53 | +40.8% | Apr 22, 2022 |
| Credit Suisse | Analyst unavailable | $250 | $206.44 | +40.8% | Apr 22, 2022 |
| Deutsche Bank | Analyst unavailable | $225 | $202.95 | +26.7% | Apr 22, 2022 |
| Goldman Sachs | George Tong | $221 | $202.95 | +24.5% | Apr 21, 2022 |
| RBC Capital | Analyst unavailable | $244 | $221.41 | +37.4% | Apr 21, 2022 |
| Morgan Stanley | Toni Kaplan | $250 | $202.95 | +40.8% | Apr 21, 2022 |
| Needham | Kyle Peterson | $275 | $202.95 | +54.9% | Apr 21, 2022 |
| Robert W. Baird | Jeffrey Meuler | $281 | $221.41 | +58.2% | Apr 20, 2022 |
| Deutsche Bank | Faiza Alwy | $265 | $214.14 | +49.2% | Apr 18, 2022 |
| Barclays | Manav Patnaik | $300 | $235.46 | +68.9% | Mar 27, 2022 |
| Cowen & Co. | Georgios Mihalos | $295 | $228.23 | +66.1% | Jan 20, 2022 |
| BNP Paribas | George Gregory | $290 | $280.26 | +63.3% | Nov 22, 2021 |
| Jefferies | Hamzah Mazari | $320 | $274.74 | +80.2% | Nov 11, 2021 |
| Argus Research | David Coleman | $285 | $267.42 | +60.5% | Oct 22, 2021 |
| Goldman Sachs | George Tong | $267 | $248.56 | +50.4% | Jul 22, 2021 |
| Credit Suisse | Kevin Mcveigh | $270 | $220.02 | +52.0% | Apr 22, 2021 |
Track every rating change on EFX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEquifax Inc. operates as a global data and analytics company, delivering a range of information solutions and specialized human resources administrative process outsourcing services. Its clientele spans across businesses, governmental organizations, and individual consumers. The company's operations are structured into three primary divisions: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment specializes in employment-related data, offering verification services for income, employment history, criminal records, and Social Security numbers. It also provides tools for payroll-based transactions, employment tax management, and products aimed at protecting against identity theft. The U.S. Information Solutions (USIS) segment provides a comprehensive suite of services for both consumers and businesses within the United States.…
Historical context
All EFX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| XPO XPO Logistics, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -3.6% | XPO pairs strong Q3 growth with AI-led efficiency gains |
| APG APi Group Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +6.5% | APi Group posts 23% growth, raises 2026 guidance |
| TXT Textron Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +14.2% | Textron raises outlook as Aviation and Systems deliver double-digit growth |
| CP Canadian Pacific Kansas City Ltd. | FY2026 Q3 · Calendar Q4 2026 | -3.2% | -1.9% | CPKC posts record Q3 as land bridge and freight volumes expand |
| LII Lennox International Inc. | FY2026 Q3 · Calendar Q4 2026 | -7.1% | -10.6% | Lennox grows revenue but cuts outlook as margins face pressure |
| IEX IDEX Corporation | FY2026 Q3 · Calendar Q4 2026 | +4.0% | +2.3% | IDEX raises 2026 outlook as advantage-market demand stays strong |
Latest beats and misses
Who reports nextBeat on EPS
- KGCFY2026 Q3 · October 28, 2026+8.7% EPS-6.1% move
- GENFY2027 Q2 · October 28, 2026+2.9% EPS+11.2% move
- KLACFY2027 Q1 · October 28, 2026+2.5% EPS+7.3% move
- SANFY2026 Q3 · October 28, 20260.0% EPS-6.3% move
- FFY2026 Q3 · October 28, 2026+19.5% EPS+1.4% move
- EQIXFY2026 Q3 · October 28, 2026+20.0% EPS+5.4% move
Missed on EPS
- AWKFY2026 Q3 · October 28, 2026-2.0% EPS+1.1% move
- CPFY2026 Q3 · October 28, 2026-3.2% EPS-1.9% move
- LIIFY2026 Q3 · October 28, 2026-7.1% EPS-10.6% move
- EXRFY2026 Q3 · October 27, 2026-1.7% EPS+0.1% move
- NOWFY2026 Q3 · October 28, 2026-2.0% EPS-3.0% move
- CMGFY2026 Q3 · October 28, 2026-7.1% EPS+2.7% move
Get the EFX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-27T02:50:40.421030+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T02:50:40.418290+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.